Global Project Manager Non-interventional studiesBayer, Berlin, GermanyBerlin, Berlin, Germany
PB1263 - Third Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol in Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World HEM-POWR Study
Tuesday, June 27, 202318:30 – 19:30 ET
